U.S. markets closed
  • S&P Futures

    4,180.00
    -3.50 (-0.08%)
     
  • Dow Futures

    34,696.00
    +28.00 (+0.08%)
     
  • Nasdaq Futures

    13,325.50
    -31.25 (-0.23%)
     
  • Russell 2000 Futures

    2,204.70
    -4.90 (-0.22%)
     
  • Crude Oil

    64.86
    -0.06 (-0.09%)
     
  • Gold

    1,836.50
    -1.10 (-0.06%)
     
  • Silver

    27.37
    -0.11 (-0.40%)
     
  • EUR/USD

    1.2146
    +0.0012 (+0.10%)
     
  • 10-Yr Bond

    1.6020
    +0.0250 (+1.59%)
     
  • Vix

    19.66
    +2.97 (+17.80%)
     
  • GBP/USD

    1.4129
    +0.0007 (+0.05%)
     
  • USD/JPY

    108.8630
    +0.0220 (+0.02%)
     
  • BTC-USD

    55,556.79
    -2,588.09 (-4.45%)
     
  • CMC Crypto 200

    1,464.56
    -96.73 (-6.20%)
     
  • FTSE 100

    7,123.68
    -6.03 (-0.08%)
     
  • Nikkei 225

    29,518.34
    0.00 (0.00%)
     

FDA approves Rockwell Medical's iron replacement drug

Jan 26 (Reuters) - The U.S. Food and Drug Administration has approved Rockwell Medical Inc's drug for treating iron loss in chronic kidney disease patients on dialysis.

The drug, Triferic, replaces the 5-7 mg of iron patients tend to lose during each dialysis session.

An advisory panel to the FDA had recommended an approval for the drug in November.

(Reporting by Anjali Rao Koppala and Amrutha Penumudi in Bengaluru; Editing by Kirti Pandey)